ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
C243532556352423 |
|
36653-82-4 |
1-Hexadecanol - 98% |
0 | C16H34O | |
C243532556352421 |
|
1662-01-7 |
Bathophenanthroline - 98% |
0 | C24H16N2 | |
C243532556352420 |
|
3068-32-4 |
2,3,4,6-Tetra-O-acetyl-alpha-D-galactopyranosyl bromide - 98% |
0 | C14H19BrO9 | |
C2435325563525 |
|
1256937-27-5 |
Evolocumab - 98% |
0 | — | |
C2435325563523 |
|
636-61-3 |
D(+)-Malicacid - 98% |
0 | C4H6O5 | |
C2435325561 |
|
477202-00-9 |
ipilimumab - 98% |
0 | — | |
C24353255635 |
|
331731-18-1 |
Unii-fys6T7F842 - 98% |
0 | — | |
C243532556 |
|
815610-63-0 |
Ustekinumab - 98% |
0 | — | |
C2435325444 |
|
1779-51-7 |
Tetrapropylammonium bromide - 98% |
0 | C22H24BrP | |
C2435325443 |
|
64057-48-3 |
Oxifungin - 98% |
0 | C13H12N4O | |
C2435325438 |
|
26264-14-2 |
PROPANEDIOL - 98% |
0 | C3H8O2 | |
C3435325435 |
|
850140-72-6 |
Afatinib - 99% |
0 | C24H25ClFN5O3 | |
C343532543543 |
|
269398-91-6 |
FMOC-(R)-3-AMINO-4-(2-NAPHTHYL)-BUTYRIC ACID - 98% |
0 | C29H25NO4 | |
C3435325435438 |
|
95233-37-7 |
4-(4-Chlorophenyl)cyclohexanecarboxylic acid - 98% |
0 | C13H15ClO2 | |
C2435325435432 |
|
1138-80-3 |
N-Carbobenzyloxyglycine - 98% |
0 | C10H11NO4 | |
C2435325435436 |
|
5680-80-8 |
L-Serine methyl ester hydrochloride - 98% |
0 | C4H10ClNO3 | |
CP235252 |
|
61618-27-7 |
amfenac sodium hydrate - 98% |
0 | C15H12NNaO3.H2O | |
CP23525 |
|
2210-25-5 |
N-Isopropylacrylamide - ≥98% |
0 | C6H11NO | |
CP23524 |
|
51012-12-5 |
Tetrabutylammonium diacetate, 98%, for synthesis - ≥98% |
0 | C20H43NO4 | |
CP23523 |
|
2438-80-4 |
L-Fucose - 98% |
0 | C6H12O5 | |